Arca biopharma announces second quarter 2023 financial results

Westminster, colo., july 21, 2023 (globe newswire) -- arca biopharma, inc. (nasdaq: abio), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported second quarter 2023 financial results and provided a corporate update.

ABIO Ratings Summary

ABIO Quant Ranking